Self-limited HBV infection of the recipient does not reactivate after liver transplantation: Observations from a 30-year liver transplant program.

Ramin Raul Ossami SaidyMuenevver DemirPauline NibbeEva Maria TeegenRobert OellingerWenzel SchoeningJohann PratschkeDennis Eurich

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2020)

Antiviral treatment with nucleos(t)ide analogues post-liver transplantation in order to prevent HBV reactivation in patients with a resolved self-limited hepatitis B infection prior to LT seems to be omittable since the main viral reservoir is removed by the hepatectomy. These findings may clarify the current uncertainty in the recommendations regarding the risk of HBV reactivation in patients with self-limited hepatitis B prior to LT.

Keyphrases

hepatitis b virus
liver failure
sars cov
quality improvement
clinical practice
liver metastases
replacement therapy
combination therapy
molecular dynamics simulations
smoking cessation